Literature DB >> 17674359

Novel spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis in ethnic Omani patients.

Shanmugakonar Muralitharan1, Yasser A Wali, David Dennison, Zakia A Lamki, Mathew Zachariah, El Banna Nagwa, Anil Pathare, Rajagopal Krishnamoorthy.   

Abstract

Familial hemophagocytic lymphohistiocytosis (FHL) is an autosomal recessive immune disorder, characterized by fever, hepatosplenomegaly, pancytopenia, hypertriglyceridemia, hypofibrinogenemia, markedly elevated levels of inflammatory cytokines, and impaired cytotoxic activity of lymphocytes. FHL is often fatal in early infancy. Histologic features include organ infiltration by activated macrophages and lymphocytes. Four genetic loci (FHL1, 2, 3, and 4) have been identified, of which FHL2 involves mutations in the perforin gene and is present in 20-50% of patients with FHL. We herein report the first comprehensive molecular analysis of 16 unrelated cases of FHL in ethnic Omanis. Using direct DNA sequencing analysis in 11 families, seven different mutations were identified in the coding region of the perforin gene, of which five were novel. Perforin gene defects do not seem to be involved in one-third of the cases of FHL in ethnic Omanis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17674359     DOI: 10.1002/ajh.21009

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  Recurrent subacute post-viral onset of ataxia associated with a PRF1 mutation.

Authors:  Cristina Dias; Allison McDonald; Murat Sincan; Rosemarie Rupps; Thomas Markello; Ramona Salvarinova; Rui F Santos; Kamal Menghrajani; Chidi Ahaghotu; Darren P Sutherland; Edgardo S Fortuno; Tobias R Kollmann; Michelle Demos; Jan M Friedman; David P Speert; William A Gahl; Cornelius F Boerkoel
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

Review 2.  Finding a Balance between Protection and Pathology: The Dual Role of Perforin in Human Disease.

Authors:  Robin C Willenbring; Aaron J Johnson
Journal:  Int J Mol Sci       Date:  2017-07-25       Impact factor: 5.923

3.  Failure of interferon gamma to induce the anti-inflammatory interleukin 18 binding protein in familial hemophagocytosis.

Authors:  Claudia A Nold-Petry; Thomas Lehrnbecher; Andrea Jarisch; Dirk Schwabe; Josef M Pfeilschifter; Heiko Muhl; Marcel F Nold
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

4.  Genetic and clinical characteristics of pediatric patients with familial hemophagocytic lymphohistiocytosis.

Authors:  Ali Al Ahmari; Osama Alsmadi; Atia Sheereen; Tanziel Elamin; Amal Jabr; Lina El-Baik; Safa Alhissi; Bandar Al Saud; Moheeb Al-Awwami; Ibrahim Al Fawaz; Mouhab Ayas; Khawar Siddiqui; Abbas Hawwari
Journal:  Blood Res       Date:  2021-06-30

Review 5.  Hemophagocytic lymphohistiocytosis: review of etiologies and management.

Authors:  Melissa R George
Journal:  J Blood Med       Date:  2014-06-12

6.  Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption.

Authors:  Robin C Willenbring; Fang Jin; David J Hinton; Mike Hansen; Doo-Sup Choi; Kevin D Pavelko; Aaron J Johnson
Journal:  J Neuroinflammation       Date:  2016-08-31       Impact factor: 8.322

7.  Late-onset hemophagocytic lymphohistiocytosis with neurological presentation.

Authors:  Sarah Benezech; Thierry Walzer; Emily Charrier; Damien Heidelberg; Geneviève De Saint-Basile; Yves Bertrand; Alexandre Belot
Journal:  Clin Case Rep       Date:  2017-09-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.